“FORT WAYNE, IN – BioPoly LLC has announced that another European patent has been granted for its partial resurfacing implants. Where many of the other BioPoly® patents address the unique material, this patent family focuses on the innovative implant designs.
With four product lines that are now regulatory approved (i.e. CE marked) in Europe, receiving additional intellectual property protection in European countries is an important part of the Company’s overall risk management plan. With BioPoly’s recent announcement that it received FDA approval to begin an IDE Clinical study in the U.S. with its BioPoly RS Partial Resurfacing Knee implant, the intellectual property portfolio provides the assurance that all aspects of the implants, material and surgical technique are protected throughout the world. ”
Click here to read full news release.